Drug Repurposing Patent Applications April–June 2021
September 2021
in “
Assay and drug development technologies
”
TLDR Drug repurposing shows promise for treating many medical conditions.
The document "Drug Repurposing Patent Applications April–June 2021" reviews various studies and findings related to the repurposing of existing drugs for new therapeutic uses. It includes research on the impact of nonsense-mediated mRNA decay on genetic diseases, the selective inhibition of FTO demethylation by meclofenamic acid, and the effects of tyrosine kinase inhibitors on drug addiction. Additionally, it covers the use of antihistamines in cancer treatment, the role of EGFR in hair differentiation and chemotherapy-induced alopecia, and the potential of SGLT2 inhibitors in cancer therapy. The document also discusses the anti-inflammatory effects of interleukin-1 receptor antagonists and the therapeutic potential of valproic acid in various conditions, including glaucoma and fibrosis. Overall, the document highlights the broad potential of drug repurposing in addressing a wide range of medical conditions.